Sunshine Biopharma
SBFM
3 hedge funds and large institutions have $111K invested in Sunshine Biopharma in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 7 closing their positions.
24% more capital invested
Capital invested by funds: $89.6K → $111K (+$21.7K)
0.28% more ownership
Funds ownership: 0.01% → 0.29% (+0.28%)
63% less funds holding
Funds holding: 8 → 3 (-5)
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$147K |
| 2 |
NA
Nordwand Advisors
Radnor,
Pennsylvania
|
+$2.13K |
| 3 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$43 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$32.1K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$18.4K |
| 3 |
HF
HRT Financial
New York
|
-$18K |
| 4 |
Jane Street
New York
|
-$11.6K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$8.35K |
SBFM Hedge Fund Activity: Q3 2024 in Review
3 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma (SBFM) for Q3 2024, worth a combined $111K — up 24% from $89.6K a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of SBFM and 2 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Bank of America, adding an estimated $147K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $32.1K sold.
- 3 institutional investors held Sunshine Biopharma (SBFM) as of Q3 2024, down from 8 in Q2 2024.
- Funds reported $111K of Sunshine Biopharma stock for Q3 2024, up 24% quarter-over-quarter.
- 2 funds opened new Sunshine Biopharma positions in Q3 2024 and 7 closed out, a net change of -5 holders.
- The largest Sunshine Biopharma buyer in Q3 2024 was Bank of America, an estimated $147K added.
- The largest Sunshine Biopharma seller in Q3 2024 was Susquehanna International Group, an estimated $32.1K sold.
Based on aggregated 13F filings for Q3 2024.